Published in J Clin Invest on December 01, 1930
INTRACELLULAR FLUID LOSS IN HEMORRHAGE. J Clin Invest (1936) 5.41
THE EFFECTS ON THE CARDIOVASCULAR SYSTEM OF FLUIDS ADMINISTERED INTRAVENOUSLY IN MAN. I. STUDIES OF THE AMOUNT AND DURATION OF CHANGES IN BLOOD VOLUME. J Clin Invest (1938) 4.97
MECHANISM OF DIURESIS: ALTERATIONS IN THE SPECIFIC GRAVITY OF THE BLOOD PLASMA WITH ONSET OF DIURESIS IN HEART FAILURE. J Clin Invest (1941) 1.15
The Management of Hypertension. Bull N Y Acad Med (1938) 0.75
THE RELATIONSHIPS BETWEEN PLASMA SPECIFIC GRAVITY, PLASMA PROTEIN CONTENT AND EDEMA IN NEPHRITIS. J Clin Invest (1930) 32.28
THE EFFECT OF POSTURE UPON THE COMPOSITION AND VOLUME OF THE BLOOD IN MAN. J Clin Invest (1928) 17.01
THE FUNCTION OF THE KIDNEYS IN PATIENTS SUFFERING FROM CHRONIC CARDIAC DISEASE WITHOUT SIGNS OF HEART FAILURE. J Clin Invest (1928) 1.70
EVIDENCE THAT DIGITALIS INFLUENCES CONTRACTION OF THE HEART IN MAN. J Clin Invest (1924) 4.10
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. BMJ (1991) 3.44
THE RELATION BETWEEN CARDIAC SIZE AND CARDIAC OUTPUT PER MINUTE FOLLOWING THE ADMINISTRATION OF DIGITALIS IN NORMAL DOGS. J Clin Invest (1928) 3.41
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
THE RELATION BETWEEN CARDIAC SIZE AND CARDIAC OUTPUT PER MINUTE FOLLOWING THE ADMINISTRATION OF DIGITALIS IN DOGS IN WHICH THE HEART IS ENLARGED. J Clin Invest (1928) 2.68
Assessment of response and recurrence in breast cancer. Semin Oncol (1978) 1.87
The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg (1985) 1.78
Invasive cribriform carcinoma of the breast. Histopathology (1983) 1.53
Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions. Development (1990) 1.47
DEPENDENCE OF THE FORM OF THE ELECTRO-CARDIOGRAM UPON THE SITE OF MECHANICAL STIMULATION OF THE HUMAN VENTRICLES. J Clin Invest (1927) 1.46
Long-term survivors after breast cancer. Br J Surg (1985) 1.38
Five years' experience with mammography. Br J Surg (1969) 1.27
Accuracy of screening methods for the diagnosis of breast disease. Br Med J (1970) 1.19
Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg (1982) 1.18
Plasma-growth-hormone levels in untreated acromegaly and after radioactive implants into the pituitary. Lancet (1965) 1.18
In-situ breast cancer: the EORTC consensus meeting. Lancet (1989) 1.13
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
Modulated expression of secreted frizzled-related proteins in human retinal degeneration. Neuroreport (2000) 1.00
GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol (1992) 1.00
The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg (1995) 0.99
Controlled trials in the treatment of "early" breast cancer: a review of published results. World J Surg (1977) 0.95
Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg (1983) 0.94
Conservation therapy of breast cancer. Lancet (1989) 0.94
Stimulation of phosphoinositide hydrolysis by oxytocin and the mechanism by which oxytocin controls prostaglandin synthesis in the ovine endometrium. Biochem J (1986) 0.92
Preoperative assessment and staging of breast cancer: preliminary communication. J R Soc Med (1980) 0.89
An interferon-induced Mx protein: cDNA sequence and high-level expression in the endometrium of pregnant sheep. Gene (1993) 0.89
Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer. Br J Cancer (1987) 0.88
Management of Pituitary Tumours. Proc R Soc Med (1965) 0.86
Radioactive implants of the pituitary for endocrine disease. Proc R Soc Med (1970) 0.86
Altered expression of secreted frizzled-related protein-2 in retinitis pigmentosa retinas. Invest Ophthalmol Vis Sci (2000) 0.85
Is the investigation of patients with breast cancer for occult metastatic disease worth while? Br J Surg (1979) 0.85
Benign and malignant breast disease in South Wales: a study of urinary steroids. Br Med J (1970) 0.84
Regulation of genes involved in Schwann cell development and differentiation. Prog Brain Res (2001) 0.83
Structure and expression of an ovine endometrial oxytocin receptor cDNA. J Mol Endocrinol (1995) 0.83
Adjuvant tamoxifen therapy and receptor levels. Lancet (1985) 0.81
Development and differentiation of Schwann cells. Rev Neurol (Paris) (1996) 0.81
The search for occult metastases in breast cancer: does it add to established staging methods? Aust N Z J Surg (1980) 0.81
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer. Eur J Cancer (1980) 0.80
Identification by array screening of altered nm23-M2/PuF mRNA expression in mouse retinal degeneration. Mol Cell Biol Res Commun (2000) 0.80
Tamoxifen and the uterus and endometrium. Lancet (1989) 0.79
The neuron-glia signal beta neuregulin induces sustained CREB phosphorylation on Ser-133 in cultured rat Schwann cells. Mol Cell Neurosci (1998) 0.79
Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Eur J Cancer (1990) 0.79
Functional characterisation of an ovine endometrial oxytocin receptor cDNA transiently expressed in Cos-7 cells. J Endocrinol (1996) 0.79
Recording the gross outlines of breast tumours. A pathological assessment of the accuracy of radiographs of breast cancers. Br J Cancer (1968) 0.78
Regulation of trophoblast interferon gene expression. Mol Cell Endocrinol (1994) 0.78
The role of the endometrial oxytocin receptor in determining the length of the sterile oestrous cycle and ensuring maintenance of luteal function in early pregnancy in ruminants. Philos Trans R Soc Lond B Biol Sci (1994) 0.78
Early pituitary implantation with yttrium-90 for advanced breast cancer. Lancet (1969) 0.78
Localization of oxytocin receptor mRNA in the ovine uterus during the oestrous cycle and early pregnancy. J Mol Endocrinol (1994) 0.78
Negative regulatory domains in a trophoblast interferon promoter. J Mol Endocrinol (1996) 0.78
A role for interferons in the maternal recognition of pregnancy. Mol Cell Endocrinol (1988) 0.77
Pituitary function after yttrium implants as measured by plasma growth hormone levels. J Endocrinol (1971) 0.77
Oestrogen receptors and primary breast cancer. Aust N Z J Surg (1982) 0.77
Is apocrine differentiation in breast carcinoma of prognostic significance? Br J Cancer (1990) 0.76
Molecular biology of trophoblast interferons and studies of their effects in vivo. J Reprod Fertil Suppl (1991) 0.76
Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy. Cancer Treat Rep (1976) 0.76
The Management of Hypertension. Bull N Y Acad Med (1938) 0.75
Which patients are cured of breast cancer? Br Med J (Clin Res Ed) (1984) 0.75
Treatment of elderly patients with breast cancer. BMJ (1992) 0.75
Prepartum milking and the onset of secretion of milk fat in the goat. J Physiol (1985) 0.75
Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival. J R Coll Surg Edinb (1991) 0.75
The BCTCS and primary breast cancer trials in the UK. Experientia Suppl (1982) 0.75
Evidence against a role for blastocyst-secreted oxytocin in early pregnancy maintenance in sheep. J Endocrinol (1991) 0.75
The management of operable breast cancer in Scotland surgeons' opinions. The Scottish Cancer Trials Breast Group. Scott Med J (1994) 0.75
The problem of management of breast cancer. J R Coll Surg Edinb (1979) 0.75
Aminoglutethimide in breast cancer. Lancet (1978) 0.75
Functional characterisation of an ovine oxytocin signal transduction pathway in oxytocin receptor cDNA transfected Cos 7 cells. Biochem Soc Trans (1995) 0.75
Recurrent Pericardial Effusion of Unknown Etiology: Report of a Case with Studies of the Circulation and of Absorption from the Pericardical Cavity. Bull N Y Acad Med (1937) 0.75
Growth-hormone test of residual pituitary function. Br J Surg (1969) 0.75
Recruitment to breast cancer trials. Lancet (1984) 0.75
Yttrium implant for advanced breast cancer. Prog Clin Biol Res (1977) 0.75
dee. 1886-1973.0dee. Trans Assoc Am Physicians (1974) 0.75
Maintenance of normal human breast organoids within rat mammary fat pads in organ culture. Virchows Arch A Pathol Anat Histopathol (1987) 0.75
ACTH initiation of mammary secretion in pregnant goats is influenced by the stage of gestation and pre partum milking. J Dairy Res (1987) 0.75
Role of the oxytocin receptor in the choice between cyclicity and gestation in ruminants. J Reprod Fertil Suppl (1992) 0.75
Selection of local therapy for primary breast cancer by lower axillary node histology. Eur J Cancer (1980) 0.75
Adjuvant therapy with 5-fluorouracil for breast cancer of likely poor prognosis: 15-year results of a randomized trial. Clin Oncol (R Coll Radiol) (1995) 0.75
Treatment decisions in breast cancer. Recent Results Cancer Res (1988) 0.75
Functional properties of a cloned ovine endometrial oxytocin receptor cDNA. Adv Exp Med Biol (1995) 0.75
The effect of node sample size on the histological node status in patients with operable breast cancer. Clin Oncol (1982) 0.75
Production of recombinant ovine interferon tau using a Bombyx mori nuclear polyhedrosis baculovirus expression system. Anim Biotechnol (2002) 0.75
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Recent Results Cancer Res (1988) 0.75
Progesterone uptake and metabolism by the goat mammary gland during lactogenesis. Br Vet J (1983) 0.75
Proceedings: Oestrogen receptor activity, plasma oetrogen concentrations and response to endocrine therapy in cancer of the breast. Br J Surg (1976) 0.75
Adrenocorticotrophic hormone stimulation of mammary secretion in lactating goats independent of increased mammary uptake of glucose. J Endocrinol (1984) 0.75
Non-surgical management of early breast cancer in the United Kingdom: ductal carcinoma in situ. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol) (1995) 0.75
Early pituitary implantation for advanced breast cancer. Br J Surg (1969) 0.75
Effects of progesterone on glucose metabolism in isolated acini from mammary glands of lactating rats. Arch Biochem Biophys (1979) 0.75
Beneficial response to pituitary ablation following aminoglutethimide. Br J Surg (1986) 0.75
The efficacy of delayed radiotherapy for locoregionally recurrent postmastectomy breast cancer. Int J Radiat Oncol Biol Phys (1988) 0.75
The sheep endometrial oxytocin receptor. Adv Exp Med Biol (1995) 0.75
The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer. Clin Oncol (1979) 0.75
Expression of the proto-oncogene fos (c-fos) by preimplantation blastocysts of the pig. Development (1989) 0.75
A controlled clinical trial to compare transethidal hypophysectomy with yttrium implant of the pituitary in the treatment of advanced breast cancer. Br J Surg (1969) 0.75
Pituitary ablation by yttrium-90. Acta Neurochir (Wien) (1974) 0.75
Effect of hypophysectomy on the growth hormone response to insulin-induced hypoglycaemia. J Endocrinol (1973) 0.75
Invasive breast cancer--where now? Br J Surg (1991) 0.75
Urinary 17-Ketosteroids and their Fractions in Women with Breast Cancer Treated by Endocrine Surgery. Br J Cancer (1960) 0.75
Accuracy of screening methods for breast disease. Br J Surg (1970) 0.75